Drug intelligence / Profile preview

Bacterelax

Development stage: Unknown
Lead developer: Astel Medica
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Oral

Overview

Bacterelax is a dietary supplement developed by Astel Medica, a Belgian company specializing in probiotic and postbiotic formulations. It is designed to support emotional balance and positive mood, particularly during periods of stress and anxiety. The formulation combines specific probiotic strains, *Lactobacillus helveticus* and *Bifidobacterium longum*, with standardized saffron extract (*Crocus sativus*), magnesium, and a complex of B vitamins (B1, B2, B3, B5, B6, B9, and B12). Unlike traditional probiotics focused on gut health, Bacterelax targets the gut-brain axis to help regulate emotional responses, support concentration, and maintain psychological function. It is marketed as a natural, non-addictive solution for cognitive and mental well-being.

Brand names: Bacterelax

Beyond the preview

Go deeper on Bacterelax.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterelax.

Explore the full profile